Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

被引：0

作者：

Anca D. Askanase

Enxu Zhao

Julie Zhu

Roman Bilyk

Richard A. Furie

机构：

[1] Columbia University Medical Center,

[2] Mallinckrodt Pharmaceuticals,undefined

[3] Zucker School of Medicine at Hofstra/Northwell,undefined

来源：

Rheumatology and Therapy | 2021年 / 8卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1915 / 1915

共 50 条

[1] Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Anca D. Askanase
Enxu Zhao
Julie Zhu
Roman Bilyk
Richard A. Furie
[J]. Rheumatology and Therapy, 2020, 7 : 893 - 908
[2] Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Askanase, Anca D.
Zhao, Enxu
Zhu, Julie
Bilyk, Roman
Furie, Richard A.
[J]. RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 893 - 908
[3] Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (vol 7, pg 893, 2020)
Askanase, Anca D.
Zhao, Enxu
Zhu, Julie
Bilyk, Roman
Furie, Richard A.
[J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1915 - 1915
[4] Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Anca D. Askanase
George J. Wan
Mary P. Panaccio
Enxu Zhao
Julie Zhu
Roman Bilyk
Richard A. Furie
[J]. Rheumatology and Therapy, 2021, 8 : 573 - 584
[5] Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Askanase, Anca D.
Wright, Dale
Zhao, Enxu
Zhu, Julie
Bilyk, Roman
Furie, Richard A.
[J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1871 - 1886
[6] Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Anca D. Askanase
Dale Wright
Enxu Zhao
Julie Zhu
Roman Bilyk
Richard A. Furie
[J]. Rheumatology and Therapy, 2021, 8 : 1871 - 1886
[7] Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar(R) Gel) for Persistently Active Systemic Lupus Erythematosus
Askanase, Anca D.
Wan, George J.
Panaccio, Mary P.
Zhao, Enxu
Zhu, Julie
Bilyk, Roman
Furie, Richard A.
[J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 573 - 584
[8] Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus: Post Hoc Analyses of Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-blind, Placebo-Controlled Trial
Askanase, Anca
Wan, George
Panaccio, Mary
Zhao, Enxu
Zhu, Julie
Bilyk, Roman
Furie, Richard
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
[9] Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
Mirsaeidi, Mehdi
Baughman, Robert P.
Sahoo, Debasis
Tarau, Eva
[J]. PULMONARY THERAPY, 2023, 9 (02) : 237 - 253
[10] Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
Mehdi Mirsaeidi
Robert P. Baughman
Debasis Sahoo
Eva Tarau
[J]. Pulmonary Therapy, 2023, 9 : 237 - 253

← 1 2 3 4 5 →